Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase I Study of Proton Therapy in Adjuvant Pancreatic Cancer (Proton-PANC)

Summary

The purpose of this phase I trial is to determine a safe schedule of short-course proton beam radiation therapy with adjuvant mFOLFIRINOX for patients with resected pancreatic adenocarcinoma.

General Information

NCT#: NCT03885284
Study ID: 2018-1021
Trial Phase: Phase I

Trial Sponsor: Georgetown University
Therapies Used in This Trial: Fluorouracil, Oxaliplatin, Proton Radiation, Irinotecan, Leucovorin, FOLFIRINOX

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search